A Rollover Protocol For Patients Who Received CP-675,206 In Other Protocols
Phase 2
N/A
N/A
N/A
N/A
Open (Enrolling)
Both
Colorectal Neoplasms, Melanoma, Prostatic Neoplasms, Renal Cell Carcinoma, Neoplasms, Patients Who Have/Have Had Melanoma and Other Tumors
Both
Colorectal Neoplasms, Melanoma, Prostatic Neoplasms, Renal Cell Carcinoma, Neoplasms, Patients Who Have/Have Had Melanoma and Other Tumors
Trial Information
A Rollover Protocol For Patients Who Received CP-675,206 In Other Protocols
Inclusion Criteria:
- The subject must have already received CP-675,206 in another protocol
- Females of childbearing potential must agree to practice a form of effective
contraception for 12 months following any dose of study drug. The definition of
effective contraception will be based on the judgement of the investigator.
- Subject must be willing and able to provide written informed consent and to comply
with scheduled visits and other trial procedures
Exclusion Criteria:
- None
Type of Study:
Interventional
Study Design:
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Outcome Measure:
Safety Endpoints: • Serious adverse events • Grade 3 or 4 CP-675,206-related adverse events • Immune-mediated adverse events • Hypersensitivity reactions to CP-675,206
Outcome Time Frame:
as long as required
Safety Issue:
Yes
Principal Investigator
Ramy Ibrahim, Senior Director
Investigator Role:
Study Director
Investigator Affiliation:
MedImmune LLC
Authority:
United States: Food and Drug Administration
Study ID:
D4881C00024
NCT ID:
NCT00378482
Start Date:
March 2008
Completion Date:
November 2014
Related Keywords:
- Colorectal Neoplasms
- Melanoma
- Prostatic Neoplasms
- Renal Cell Carcinoma
- Neoplasms
- Patients Who Have/Have Had Melanoma and Other Tumors
- Melanoma and other tumors
- Neoplasms
- Carcinoma
- Carcinoma, Renal Cell
- Colorectal Neoplasms
- Melanoma
- Prostatic Neoplasms
Name | Location |
|---|---|
| Research Site | Alabaster, Alabama |
| Research Site | Bentonville, Arkansas |
| Research Site | Anaheim, California |
| Research Site | Boulder, Colorado |
| Research Site | Boca Raton, Florida |
| Research Site | Bloomington, Indiana |
| Research Site | Battle Kreek, Michigan |
| Research Site | Albany, New York |
| Research Site | Allentown, Pennsylvania |
| Research Site | Abilene, Texas |
| Research Site | Appleton, Wisconsin |
